Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 13, 2002

View Archived Issues

NeuroSearch, Ingelheim Enter $80M Alliance Around NS2330

Shares in NeuroSearch A/S surged more than 50 percent Friday on news of its largest ever deal, a US$80 million pact with Boehringer Ingelheim GmbH to develop its candidate Alzheimer’s and Parkinson’s drug, NS2330. (BioWorld International) Read More

Irish Government Backs EUR15M Biotech Life Sciences Seed Fund

Genetic Tests Predict Cancer Risks, Melanoma Study Shows

EU Officials Want Legislation Covering Tissue, Cell Implants

Proteom Raises £3M To Further Work Around Protein Interactions

Other News To Note

Transgene Says Restructuring In Place, Products Moving Along

Scancell Partners Antibody Drug In Asia With Korean Company

Metabolic Eyeing Phase IIb Trial In Obesity After Positive IIa Study